This review paper highlights preclinical and clinical studies indicating that GLP-1 drugs, including low dose formulations such as exenatide, may offer neuroprotective benefits by targeting hallmarks of brain aging through enhancing DNA repair, boosting antioxidant responses, reducing inflammation and improving mitochondrial function
The 2024 quality indicators for colonoscopy provide clear benchmarks for preparation adequacy [8]
Because its in pill form, there are a few key differences for dosing and administration of this medication, compared to GLP-1 medications
At the same time, demand for preventative care, diagnostics, and ongoing health monitoring could increase as consumers place greater emphasis on long-term wellbeing rather than acute treatment
PMID: 12626323 A novel glucagon receptor antagonist inhibits glucagon-mediated biological effects